Correction: Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer

In the original version of this article (1), two references that provide details about the mice used for the study were omitted within the Results section. In the subsection titled “Establishment of Brca1-deficient and Brca1-WT TNBC Mouse Models” on page 356, a citation to ref. 2 (below) has been added at the end of the following sentence: “We generated two cohorts of mice to model both BRCA1-germline mutation carriers and sporadic TNBCs: K14cre; Trp53^flox/flox; Brca1^flox/flox, defined as Brca1-deficient cohort; and K14cre; Trp53^flox/flox; Brca1^wt/wt, defined as Brca1 wild-type (WT) cohort (Supplementary Fig. S1A).” In the subsection “Tumors Harboring FGFR2 Fusion Proteins Are Responsive to FGFR2 Inhibition In Vivo, Resulting in Complete Tumor Regression” on page 361, a citation to ref. 3 (below) has been added at the end of the following sentence: “To this end, we transplanted mouse TNBC tumors with identifiable potential genetic drivers in cohorts of nude mice.” The references have been updated in the latest online HTML and PDF versions of the article. The authors regret this error.